Research & Development



  “媽媽問我為什麼要跪著看手機......”   他回到寢室的第一件事就是找充電器充電,剛充上電就迫不及待的按下開機鍵,剛開機就收到了好幾條微信消息。20元彩票中奖   一大早晨練遛狗的人還挺多,兩人同穿著同款衛衣走在小區的花園里,秋日的晨光照在身上暖融融的。25号体育彩票中奖号码   “不會。”林徵羽又剝好一個小龍蝦, 放進他面前的古瓷盤里,“在素質廣場準備的時候我特意看過,衣服雖然有穿一樣的,但同款戴圍巾的只有他一個。” 第五十五章300期福彩正虹彩票   他最近有想成立個配音工作室,覺得陸昔年實在是個好苗子,知道他還是學生就想提前把人拉過來。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo